Eli Lilly

Lilly, a global pharmaceutical company based in Cambridge, is dedicated to combining compassion with innovation to develop medications that enhance the quality of life for individuals worldwide. Through their commitment to discovery and empathy, Lilly strives to improve healthcare outcomes and provide solutions that positively impact the well-being of people across the globe. Generated from their website's infomation

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Formerly known as Millennium Pharmaceuticals